| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36064 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate |
2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c669db561c1c744a1ea5fc6db7606cd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d23be7f5a3dbd6c42aea2e34b51713e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d7ca75bf816433fa0a9c9bf72ef7184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d985c089f7b7687215581f49a2f9963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760a2c7e714b2657cf38e3ad64a06559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c8a5573d02f5abc6450673a03cf855 |
| publicationDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013274091-B2 |
| titleOfInvention |
Therapy delivery devices and methods for non-damaging neural tissue conduction block |
| abstract |
Devices and methods for blocking signal transmission through neural tissue. One step of a method includes placing a therapy delivery device into electrical communication with the neural tissue. The therapy delivery device includes an electrode contact having a high charge capacity material. A multi-phase direct current (DC) can be applied to the neural tissue without damaging the neural tissue. The multi-phase DC includes a cathodic DC phase and anodic DC phase that collectively produce a neural block and reduce the charge delivered by the therapy delivery device. The DC delivery can be combined with high frequency alternating current (HFAC) block to produce a system that provides effective, safe, long term block without inducing an onset response. |
| priorityDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |